Dear Charles,
I agree with others here that it is a misrepresentation to suggest that the response to the MEGA petition with a counter petition is an attempt to stop the project in its tracks. That is not what is said or intended as I understand it. I think the original petition was disingenuous and a response is entirely fair.
With regard to the question about the Biobank material. Whether this is included will be a matter of practicality but I would hope it would be, since that was the whole point of collecting it. My own calculations indicate that a cohort of about 1,000 ME cases would be appropriate, based on previous genomic publications and the Biobank goes quite a way to that. What I think is more important is that any study of the sort planned by MEGA should have as high quality patient selection and documentation as the Biobank. Large scale studies of this sort can be completely useless if cohorts are not properly selected. The subjects and controls have to be matched for race in some detail, and also need to reflect true demographics. CFS clinic lists are unlikely to be much help to us.
My own real concern here is that the team shouldn't include those who have demonstrated that they do not understand basic research methodology. I will not name names but anyone who still supports the PACE study after all that we now know from patients' analyses will fall into that category. I have no preconceptions about any hypothesis being better than another (although I do like hypotheses to be coherent!) but individuals who have shown themselves not to understand scientific method should not be allowed to prevail for political reasons.
Hi Jonathan
Thanks for these very helpful and constructive comments about patient selection and the use of the ME Biobank samples
For the record, I have already stated that as Peter White has retired/resigned from the MEGA planning group (and the Board of the CMRC) he should now terminate all involvement with the MEGA study
And as we have been endlessly discussing, the protocol is still being discussed and developed - so I am keen to hear what people with expertise in this area of research have to say about the way in which this MEGA proposal should now be developed - because I support the aims of the study
My personal view is that it would be very helpful if you would be willing to submit a more detailed analysis of how you feel the patient selection process for a 'big data' -omics study should be carried out
Regarding the petitions - reading all the comments on PR it's difficult to find anyone who wants to see the MEGA study proceed, even if changes to the personnel were made. I don't sense any real enthusiasm on PR for a big data -omics study!
Charles